The Efficacy of Adalimumab as an Initial Treatment in Patients with Behçet's Retinal Vasculitis
Background: No study has evaluated the effectiveness of Adalimumab (ADA) as first-line in treatment-naïve patients with retinal vasculitis due to Behçet's Uveitis (BU).Objective: To compare the efficacy of ADA plus conventional therapy and conventional therapy alone as initial treatments in naï...
Saved in:
Main Authors: | Shizhao Yang (Author), Zhaohao Huang (Author), Yunwei Hu (Author), Jian Zhang (Author), Xiuxing Liu (Author), He Li (Author), Lihui Xie (Author), Feng Wen (Author), Dan Liang (Author), Wenru Su (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets' Disease-Associated Uveitis: A Systematic Review and Meta-Analysis
by: Yunwei Hu, et al.
Published: (2020) -
Early administration of adalimumab for paediatric uveitis due to Behçet's disease
by: Tomona Hiyama, et al.
Published: (2019) -
Recalcitrant Acneiform Eruption Revealing Behçet's Disease: A Case with Late but Successful Response to Adalimumab
by: Júlia Vide, et al.
Published: (2018) -
Drug-induced lupus with leukocytoclastic vasculitis: a rare expression associated with adalimumab
by: Carolina Forte Amarante, et al.
Published: (2015) -
Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet's disease and autoinflammation. A viewpoint
by: A. Colangelo, et al.
Published: (2023)